Charles River Laboratories International Inc’s recently made public that its Chairman, President and CEO FOSTER JAMES C acquired Company’s shares for reported $1.0 million on Feb 20 ’25. In the deal valued at $165.01 per share,6,075 shares were bought. As a result of this transaction, FOSTER JAMES C now holds 183,639 shares worth roughly $32.49 million.
Then, Girshick Birgit bought 1,514 shares, generating $249,250 in total proceeds. Upon buying the shares at $164.63, the Corporate Executive VP & COO now owns 55,058 shares.
Before that, LaPlume Joseph W sold 4,400 shares. Charles River Laboratories International Inc shares valued at $715,000 were divested by the EVP, Corp Strategy & Develop at a price of $162.50 per share. As a result of the transaction, LaPlume Joseph W now holds 20,013 shares, worth roughly $3.54 million.
Citigroup upgraded its Charles River Laboratories International Inc [CRL] rating to a Neutral from a a Sell in a research note published on March 04, 2025; the price target was increased to $175 from $155. A number of analysts have revised their coverage, including Redburn Atlantic’s analysts, who increased its forecast for the stock in early March from “a Sell” to “a Neutral”. William Blair also remained covering CRL and has decreased its forecast on January 22, 2025 with a “Mkt perform” recommendation from previously “an Outperform” rating. UBS revised its rating on January 17, 2025. It rated CRL as “a Neutral” which previously was an “a Buy”.
Price Performance Review of CRL
On Tuesday, Charles River Laboratories International Inc [NYSE:CRL] saw its stock jump 1.10% to $176.94. Over the last five days, the stock has gained 6.19%. Charles River Laboratories International Inc shares have fallen nearly -4.15% since the year began. Nevertheless, the stocks have fallen -32.08% over the past one year. While a 52-week high of $274.77 was reached on 01/07/25, a 52-week low of $150.79 was recorded on 02/12/25. SMA at 50 days reached $168.39, while 200 days put it at $193.29.
Levels Of Support And Resistance For CRL Stock
The 24-hour chart illustrates a support level at 174.34, which if violated will result in even more drops to 171.73. On the upside, there is a resistance level at 178.33. A further resistance level may holdings at 179.72. The Relative Strength Index (RSI) on the 14-day chart is 59.63, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 4.83, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 23.15%. Stochastics %K at 63.43% indicates the stock is a holding.
How much short interest is there in Charles River Laboratories International Inc?
A steep rise in short interest was recorded in Charles River Laboratories International Inc stocks on 2025-02-28, growing by 0.93 million shares to a total of 2.93 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 2.0 million shares. There was a rise of 31.88%, which implies that there is a positive sentiment for the stock.
